Kevin Hagan, CEO, Pan Foundation, discusses central concerns for patient assistance programs as changes to Medicare and the Inflation Reduction Act take effect.
New facility is expected to serve as a global hub for accelerating the development of next-generation antibody-drug ...
In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy officer at the National Pharmaceutical Council, describes how accumulators, ...
In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief ...
The parties aim to create an end-to-end digital thread that links research data all the way through to life sciences ...
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief ...
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief ...
Jen Butler, chief commercial officer, Pleio, discusses the importance of balancing technology and personalization in patient ...
Jen Butler, chief commercial officer, Pleio, discusses how personalization, connectivity, technology, and proactive support ...
The telehealth company is offering Lilly’s branded form of tirzepatide—approved for weight loss—on its site for $1,899 a ...
Jen Butler, chief commercial officer, Pleio, discusses the effectiveness of peer-to-patient outreach when starting specialty ...
Renier Brentjens, MD, PhD outlines the evolution of the space, while offering ways to boost patient access to these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback